Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Withdrawn 2Completed 2Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Breast Neoplasms 10Neoplasms 9Polycystic Ovary Syndrome 8Infertility 5Liver Neoplasms 4Pain, Postoperative 3Neoplasm Metastasis 3Multiple Myeloma 3Lung Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Recurrence 2Pulmonary Embolism 2Prostatic Neoplasms 2Pleural Effusion 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroma, Acoustic 2Melanoma 2Lymphoma, Follicular 2Leiomyoma 2Inflammation 2Febrile Neutropenia 2Colorectal Neoplasms 2Bites and Stings 2Anovulation 2Vomiting 1Venous Thrombosis 1Venous Thromboembolism 1

Interventions

Deoxyribonucleases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Pulmonary Embolism × Clear all
NCT03167281 2025-02-21

ELEVATE

Prisma Health-Midlands

Phase 4 Withdrawn
Thoracic

Lung Neoplasms, Pleural Diseases, Pleural Effusion, Pneumothorax, Pulmonary Embolism

NCT03988231 2021-10-08

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

University of Utah

Phase 4 Withdrawn
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡